Published: December 3rd 2024 | Updated: December 6th 2024
ASH 2024 Preview for Community Oncologists: The Show and After Show
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: August 10th 2021 | Updated: May 15th 2025
FDA Accepts sBLA for Pembrolizumab Monotherapy for Endometrial Cancer
Published: October 13th 2021 | Updated: May 15th 2025
FDA Approves Pembrolizumab With Chemotherapy for PD-L1+ Recurrent or Metastatic Cervical Cancer
Published: February 7th 2022 | Updated: May 15th 2025
Part 1: Sacituzumab Shows Efficacy in Second-Line Metastatic TNBC
Published: April 7th 2025 | Updated: May 15th 2025
Incorporating MRD Into Monitoring After Fixed-Duration CLL Treatment